Abeer Al Tuwaijri1, Valérie Gagné-Ouellet2, Anne-Marie Madore2, Catherine Laprise2, Anna K Naumova3. 1. Department of Human Genetics, McGill University, Montreal, Quebec, Canada. 2. Département des sciences fondamentales, Université du Québec à Chicoutimi, Chicoutimi, Quebec, Canada. 3. Department of Human Genetics, McGill University, Montreal, Quebec, Canada Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
Abstract
BACKGROUND: Two asthma-associated regions 17q12-q21 and 5q31.1 harbour genes that show strong effect of genotype on expression levels. DNA methylation has an important role in gene regulation; therefore, we examined DNA methylation at promoters of 12 genes from 5q31 and 17q12-q21 regions. Our goal was to determine whether DNA methylation was associated with predisposition to asthma and whether such a relationship was independent from genetic association. METHODS: Using sodium bisulfite sequencing and pyrosequencing methylation assays, we examined the effect of genotype on DNA methylation in peripheral blood cells from individuals from the Saguenay-Lac-Saint-Jean asthma familial collection and lymphoblastoid cell lines. RESULTS: The local genotype influenced methylation levels of solute carrier family 22 (organic 3 cation/carnitine transporter) member 5 (SLC22A5), zona pellucida binding protein 2 (ZPBP2) and gasdermin A (GSDMA) promoter regions. The genotype had a dominant effect on ZPBP2 and GSDMA methylation with lower methylation levels in individuals that carry the asthma-predisposing alleles. Males also had lower methylation at the ZPBP2 promoter than females. We did not observe an effect of asthma status that would be independent of the genotype and the sex effects in the GSDMA, ZPBP2 and SLC22A5 regions; however, GSDMA and ZPBP2 data were suggestive of interaction between asthma and methylation levels in females and SLC22A5 in males. CONCLUSIONS: The local genotype influences methylation levels at SLC22A5 and ZPBP2 promoters independently of the asthma status. Further studies are necessary to confirm the relationship between GSDMA-ZPBP2 and SLC22A5 methylation and asthma in females and males separately. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
BACKGROUND: Two asthma-associated regions 17q12-q21 and 5q31.1 harbour genes that show strong effect of genotype on expression levels. DNA methylation has an important role in gene regulation; therefore, we examined DNA methylation at promoters of 12 genes from 5q31 and 17q12-q21 regions. Our goal was to determine whether DNA methylation was associated with predisposition to asthma and whether such a relationship was independent from genetic association. METHODS: Using sodium bisulfite sequencing and pyrosequencing methylation assays, we examined the effect of genotype on DNA methylation in peripheral blood cells from individuals from the Saguenay-Lac-Saint-Jean asthma familial collection and lymphoblastoid cell lines. RESULTS: The local genotype influenced methylation levels of solute carrier family 22 (organic 3 cation/carnitine transporter) member 5 (SLC22A5), zona pellucida binding protein 2 (ZPBP2) and gasdermin A (GSDMA) promoter regions. The genotype had a dominant effect on ZPBP2 and GSDMA methylation with lower methylation levels in individuals that carry the asthma-predisposing alleles. Males also had lower methylation at the ZPBP2 promoter than females. We did not observe an effect of asthma status that would be independent of the genotype and the sex effects in the GSDMA, ZPBP2 and SLC22A5 regions; however, GSDMA and ZPBP2 data were suggestive of interaction between asthma and methylation levels in females and SLC22A5 in males. CONCLUSIONS: The local genotype influences methylation levels at SLC22A5 and ZPBP2 promoters independently of the asthma status. Further studies are necessary to confirm the relationship between GSDMA-ZPBP2 and SLC22A5 methylation and asthma in females and males separately. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Authors: Cynthia Kanagaratham; Victoria Chiwara; Bianca Ho; Sanny Moussette; Mina Youssef; David Venuto; Lucie Jeannotte; Guillaume Bourque; Juan Bautista de Sanctis; Danuta Radzioch; Anna K Naumova Journal: Mamm Genome Date: 2018-03-13 Impact factor: 2.957
Authors: Bianca Ho; Keelin Greenlaw; Abeer Al Tuwaijri; Sanny Moussette; Francisco Martínez; Elisa Giorgio; Alfredo Brusco; Giovanni Battista Ferrero; Natália D Linhares; Eugênia R Valadares; Marta Svartman; Vera M Kalscheuer; Germán Rodríguez Criado; Catherine Laprise; Celia M T Greenwood; Anna K Naumova Journal: Biol Sex Differ Date: 2018-02-20 Impact factor: 5.027
Authors: Matthew L Chang; Sanny Moussette; Enrique Gamero-Estevez; José Héctor Gálvez; Victoria Chiwara; Indra R Gupta; Aimee K Ryan; Anna K Naumova Journal: PLoS One Date: 2019-09-27 Impact factor: 3.240